Jill M. Quigley, Director at Terns Pharmaceuticals, Inc. (TERN), sold 14,765 shares at $10.00 ($148K) on 2024-07-15, disclosed to the SEC on 2024-07-17.
Scheduled sale ($148k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.00 | 14,365 | $144K | 97.3% |
| 2 | $10.00 | 400 | $4K | 2.7% |
| Total | $10.00 avg | 14,765 | $148K | 100% |
| Filing → |
| TERN | SELL | 2024-09-11 | $172K | — | Filing → |
| TERN | SELL | 2024-08-05 | $180K | — | Filing → |
| PASG | SELL | 2021-01-22 | $39K | — | Filing → |